J0172 Injection, aducanumab-avwa, 2 mg

Short descriptor: Inj, aducanumab-avwa, 2 mg

⚠ Terminated HCPCS Level II 2026
Terminated Code
J0172 was terminated as of 2025-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open J0172 in the app →

Look up J0172 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J0172 is the HCPCS Level II code for Injection, aducanumab-avwa, 2 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Not separately priced by Part B.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Not separately priced by Part B (indicator 00)
Type of Service
Medical care
Effective Date
2026-01-01
Termination Date
2025-12-31
2026 Maintenance
Discontinued

Drug Details

Drug / Substance
aducanumab-avwa
Dose / Unit
2 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J0172 with the canonical source and edition:

J0172 — Injection, aducanumab-avwa, 2 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0172

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0172

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial